Dry Powder Inhaler Market is
expected to display higher growth rate in the upcoming period. Rapid surge in
the market is credited to the prevalence of respiratory diseases such as
chronic obstructive pulmonary diseases and asthma, and rising air pollution
levels, particularly in developing economies across the globe. Rising efforts
by local governments for improving existing healthcare infrastructure and
growing awareness levels are expected to drive the growth of the market over
the forecast period.
Rising demand and consumption of dry powder inhalers is
credited to the surging per capita health care expenditure by regional
governments across the globe. Growing preference towards self-administered drug
therapies and home-based healthcare services are anticipated to fuel market
demand for dry powder inhaler market over the forecast period. Globally, market
is predicted to generate massive revenue over the forecast period, providing
numerous opportunities for industry participants to invest in research and
development of dry powder inhalers.
Request Sample Copy
of this Market Research @ https://www.millioninsights.com/industry-reports/dry-powder-inhaler-market/request-sample
Growing consumption of nicotine and tobacco-based product is
propelling sales of dry powder inhaler over the past few years. Development of
inexpensive therapies associated with different respiratory diseases, and
soaring demand for low-cost devices from developing & underdeveloped
economies across the globe is further fostering market growth over the past few
years.
The dry powder inhaler market is broadly categorized into
three major segments based on the product type such as capsule based dry powder
inhaler device, blister based powder inhaler device, and reservoir/cartridge
based powder inhaler device. Capsule based dry powder inhaler device segment is
growing rapidly in the market with substantial revenue generation in the last
few years. Growing popularity of capsule based dry powder inhaler device
segment is attributed to the increasing product penetration in newer market and
cost-effectiveness.
The dry powder inhaler market is divided by region as North
America, Europe, Asia-Pacific, Latin America and Africa. North America has
shown major growth in recent years owing to the rise in implementation of
latest technologies in medicine & pharmaceutical sector, surge in number of
research & development activities and existence of well-established healthcare
infrastructure in the region. In European region, Germany, France and United
Kingdom are projected to witness steady growth over the past few years.
The key players in the dry powder inhaler market are
Mannkind Corp., Cipla Inc., Hovione FarmaCiencia S.A., GlaxoSmithKline plc,
Meda Pharmaceuticals Inc., The 3M Company, AstraZeneca plc, Vectura Group plc,
Teicos Pharma Ltd., and Teva Pharmaceutical Industries.
Browse Complete
Report with TOC @ https://www.millioninsights.com/industry-reports/dry-powder-inhaler-market
No comments:
Post a Comment